Price Drop: Ozempic Now Affordable

Ozempic injection pen and packaging for diabetes treatment — OZEMPIC PRICE DROPPED?

President Trump’s bold drug pricing deals have slashed costs for life-changing GLP-1 weight loss drugs and fertility medications in half, delivering real relief to struggling American families long gouged by Big Pharma and past failed policies.

Story Highlights

GLP-1 drugs like Ozempic and Wegovy now cost $245-$350 monthly on TrumpRx.gov, down from over $1,000, enabling Medicare obesity coverage for the first time.
Fertility drugs such as Gonal-F and Cetrotide dropped up to 84%, saving thousands per IVF cycle and boosting family-building access.
CMS Director Chris Klomp confirms patients pay roughly half at pharmacies, addressing the 25% who skipped prescriptions due to cost.
Trump’s Most-Favored-Nation strategy uses tariffs and FDA leverage to force international pricing, reversing Biden-era hikes.

Trump Administration Delivers Immediate Savings

CMS Medicare Director Chris Klomp announced on Fox Business that President Trump’s initiatives have halved prices for GLP-1 drugs used in diabetes and weight-loss management.

Patients now pay roughly half as much at the pharmacy counter as they did months ago. These reductions address key affordability barriers, with GLP-1s dropping from list prices exceeding $1,000 per month.

Klomp emphasized the changes enable healthier lives for everyday Americans frustrated by skyrocketing healthcare costs under prior administrations.

TrumpRx.gov Launches with Game-Changing Discounts

TrumpRx.gov launched in February 2026, offering direct-to-consumer discounts on over 40 drugs, including semaglutide products like Ozempic and Wegovy, tirzepatide such as Zepbound, and fertility injectables.

GLP-1s retail at $245-$350 per month for cash-pay patients, half the prior levels. Medicare and Medicaid secure $245 pricing over 24 months, far below Biden’s proposals of over $500.

The platform aggregates manufacturer coupons, helping uninsured Americans bypass Big Pharma’s inflated list prices.

Americans paying less as Trump drug pricing push slashes GLP-1, fertility medicine costs, official says https://t.co/9Zt7wC06qp

— FOX Business (@FoxBusiness) April 7, 2026

Fertility medications from EMD Serono, including Gonal-F at $168 per pen and Cetrotide from $316 to $22.50, reflect 84% Most-Favored-Nation discounts. These stem from an October 2025 deal granting tariff exemptions for U.S. manufacturing.

IVF patients save over $2,000 per cycle on meds alone, countering out-of-pocket burdens averaging $3,000-$7,000 previously. This supports family values by making parenthood more accessible without government handouts.

Strategic Leverage Forces Pharma Concessions

President Trump revived Most-Favored-Nation pricing, tying U.S. costs to lower international rates using Section 232 tariffs and FDA priority reviews as leverage.

Eli Lilly and Novo Nordisk agreed to $245 Medicare pricing for weight loss coverage in exchange for exemptions.

This reverses Biden-era policies that locked in higher prices. White House fact sheets confirm Ozempic falls from $1,000 to $350 on TrumpRx, with oral versions at $150 if approved.

Deals with EMD Serono followed in late 2025, extending savings to Ovidrel and other IVF essentials. Admin sources highlight these as political wins, fulfilling campaign promises on affordability.

Critics from left-leaning groups claim limited scope, noting prior coupons matched many discounts and 22 million face rises elsewhere.

However, Klomp’s on-air verification and cross-source price matches affirm tangible pharmacy impacts for millions.